ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,696
Screening encounters
3,005
Diagnostic referrals
587
Outstanding pathways
233

Screening pathway

  1. Screening3,005Encounters
  2. Positive finding1,027Documented findings
  3. Referral587Diagnostic referrals
  4. Follow-up661Diagnostic visits
  5. Outcome354Resolved pathways

Stage totals use different units. Pending pathways: 233. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 4354 · EXP-4354Synthetic · Site E

Full participant history through 2026-04-26, across modalities and pathways.

  1. · Screening · Cytology · Initial · Programme entry
  2. · Screening result · Cytology · HSIL · Adequate
  3. · Diagnostic referral · EXP-4354-T-R
  4. · Contact attempt · Unsuccessful
  5. · Diagnostic booking · Initial booking
  6. · Contact attempt · Reached
  7. · Barrier documented · Contact difficulty
  8. · Diagnostic visit · Attended
  9. · Diagnosis · Colposcopy · Biopsy collected
  10. · Navigation intervention · Coordination support
  11. · Diagnosis · Histopathology · No high-grade lesion identified
  12. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-03-30
  13. · Follow-up disposition · Resolved · EXP-4354-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

2696 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-3239 · Expanded synthetic participant 3239Site A — Urban Referral Hub
EXP-3240 · Expanded synthetic participant 3240Site C — Rural Outreach Programme
EXP-3242 · Expanded synthetic participant 3242Site E — Resource-Constrained Navigation Programme
EXP-3243 · Expanded synthetic participant 3243Site A — Urban Referral Hub
EXP-3246 · Expanded synthetic participant 3246Site D — Community Engagement Programme
EXP-3247 · Expanded synthetic participant 3247Site D — Community Engagement Programme
EXP-3248 · Expanded synthetic participant 3248Site E — Resource-Constrained Navigation Programme
EXP-3249 · Expanded synthetic participant 3249Site C — Rural Outreach Programme
EXP-3250 · Expanded synthetic participant 3250Site B — Peri-Urban Access Programme
EXP-3252 · Expanded synthetic participant 3252Site D — Community Engagement Programme
EXP-3257 · Expanded synthetic participant 3257Site A — Urban Referral Hub
EXP-3259 · Expanded synthetic participant 3259Site D — Community Engagement Programme
EXP-3261 · Expanded synthetic participant 3261Site E — Resource-Constrained Navigation Programme
EXP-3262 · Expanded synthetic participant 3262Site A — Urban Referral Hub
EXP-3265 · Expanded synthetic participant 3265Site E — Resource-Constrained Navigation Programme
EXP-3266 · Expanded synthetic participant 3266Site C — Rural Outreach Programme
EXP-3267 · Expanded synthetic participant 3267Site B — Peri-Urban Access Programme
EXP-3268 · Expanded synthetic participant 3268Site B — Peri-Urban Access Programme
EXP-3269 · Expanded synthetic participant 3269Site B — Peri-Urban Access Programme
EXP-3270 · Expanded synthetic participant 3270Site A — Urban Referral Hub
EXP-3271 · Expanded synthetic participant 3271Site B — Peri-Urban Access Programme
EXP-3274 · Expanded synthetic participant 3274Site D — Community Engagement Programme
EXP-3277 · Expanded synthetic participant 3277Site D — Community Engagement Programme
EXP-3281 · Expanded synthetic participant 3281Site B — Peri-Urban Access Programme
EXP-3284 · Expanded synthetic participant 3284Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
1238
HPV DNA
1320
Cytology
447

Navigation activity

Barrier documented
495
Contact attempt
857
Navigation intervention
213
Diagnostic booking
719
Diagnostic visit
661

Documented barriers

Contact difficulty
161
Transport difficulty
151
Appointment coordination
183

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.